The hemorheologic abnormalities were studied in patients suffering from thromboangiitis obliterans (TAO) and compared findings with those of patients suffering from critical limb ischemia because of peripheral atherosclerotic obstructive disease (PAOD) and the healthy subjects. This prospective study included 20 patients with TAO, 20 patients with PAOD, and 20 healthy subjects. Hematocrit, plasma fibrinogen, red blood cell rigidity, and blood and plasma viscosity were determined in all groups. Hematocrit values of the TAO group were significantly higher than those of the PAOD group and the control group (p<0.001 and p<0.001, respectively). BV at a shear rate of 6.00 sec-1 was higher in TAO than the PAOD and control Thromboangiitis obliterans (TAO, Buerger's disease) is a nonatherosclerotic, inflammatory, segmental vascular occlusive disease that primarily affects medium and small sized arteries of the limbs (1). It is mainly seen in young male smokers with the onset of symptoms before the age of 50 years. Diagnosis is made on the basis of clinical criteria established by Shionoya (2). Although TAO is classified as one of the vasculitis syndromes, it has several distinguishing features that make it different from other vasculidies. In TAO patients, the immunologic markers are normal or negative, and there is a highly cellular thrombus. Regardless of the pathologic state, the internal Address correspondence and reprint requests to .
elastic lamina remains intact and the general architecture of the vessel wall is preserved in TAO, in contrast to atherosclerosis (3) .
The role of impaired hemorheologic parameters in the progression of tissue ischemia in atherosclerotic vascular disease is well established (4, 5) . Elevated blood viscosity (BV) and plasma viscosity (PV) are recognized as strong risk factors for vascular disease and have an important impact on the further reduction of blood flow in microcirculation distal to a arterial stenosis (6, 7) .
Drug therapies, such as pentoxifylline, improve BV and erythrocyte membrane deformability (EMD) and have been shown to decrease rest pain in critical limb ischemia in peripheral atherosclerotic obstructive disease (PAOD) (8, 9) .
Tissue ischemia is the ultimate result of TAO and most patients had ischemic ulcerations at presentation. Any factor leading to further reduction in tissue oxygenation may contribute to the worsening of the clinical course, and ampu-tation may be inevitable. Thus, the altered hemorheologic parameters in patients with TAO should be known to design a more effective medical treatment. The aim of this study was to determine the hemorheologic parameters in patients with TAO, and compare the results with those with PAOD suffering from critical limb ischemia and healthy control subjects.
MATERIALS AND METHODS
Approval for this study was obtained from the research ethics committee of the Istanbul University Cerrahpasa Medical Faculty. Patients and healthy control subjects gave their approval after receiving verbal and written information.
Patients and Control Population
There were 20 male patients (mean age, 35.5+6.5; range, 24 47 years) in the TAO group on whom diagnosis was made according to the clinical criteria proposed by Shionoya (2) as outlined below:
1. Onset of the symptoms before the age of 50 years 2. A history of smoking 3. Infrapopliteal arterial occlusive lesions 4. Either upper limb involvement or thrombophelibitis migrans 5. Absence of atherosclerotic risk factors other than smoking Digital subtraction angiography was obtained and routinely demonstrated typical features for TAO, like corkscrew or "tree root" appearance. All patients were examined during the active period of the disease and they were all suffering from rest pain (n=4) and ischemic ulcers (n= 16).
In the PAOD patient group, there were 20 male patients (mean age, 58.5+8.5; range, 43-72 years) with clinically evident superficial femoral artery occlusive disease. They were candidates for femoro-popliteal or femoro-distal revascularization and were all suffering from rest pain (n=5) and ischemic ulcer (n= 15). The control subjects were all males and selected (mean age, 49.6+9.2; range, 37-65 years) from members of the healthy population without clinically evident atherosclerotic disease. The subjects included in the study were non-diabetics with blood pressure measurements within the normal range. The subjects took no compounds known to interfere with platelet function and hemorheologic parameters for at least 7 days before investigation.
Blood Sampling
The patients in PAOD group underwent sampling 1 day before surgery. Blood specimens were taken from the subjects' antecubital veins and put into anticoagulant tubes containing lithium-heparin (20 IU/mL) after at least a 12-hour overnight fasting. Hematocrit (Hct) values were determined on EDTA-anticoagulated blood samples by electronic counter (Medonic CA 570, Sweden). The blood was centrifuged at 4000 rpm for 10 minutes. Plasma was separated and the buffy coat was discarded. Samples for the hemorheologic study were collected in tubes containing EDTA and were processed in 1 hour following collection in accordance with the Committee of Hemorheology Standardization (International Committee, 1986) (10).
Hemorheologic Measurements
BV was measured in the uncentrifuged EDTA containing blood samples within 1 hour of sample collection, using a digital cone and plate viscometer (Brookfield LVDV III viscometer, Stougthon, MA) linked to a mainframe computer. Viscosity data were collected directly from the viscometer in the standardized way, using a viscosity gather program. Temperature was kept constant at 37°C and a CP42 spindle was used. Before determination of BV, the viscometer was standardized, using a Newtonian silicone standard (4.9 Pas). BV of a 1-mL aliquot of blood was determined at two shear rates (6.00 1/sec and 225 1/sec) (11) . PV was measured using a Harkness capillary viscometer (Coulter Electronics, serial number 6083, England) and evaluated in relation to distilled water at 37°C (12) . The BV and PV were expressed in milipascals (mPas). The intra-assay coefficients of variation for PV were 3.8% and 4.0%, respectively. With this device we measured the apparent viscosity of blood at native Hct: PV and BV were measured at corrected Hct (0.45) according to the equation of Matrai (13). Dintenfass' "Tk" index of erythrocyte rigidity was calculated as follows (14) :
H being hematocrit given as volume fraction; nr is the relative viscosity of blood (BV derived by PV; at shear rate sufficient disaggregation of red blood cells). An increase in the rigidity index indicates a decrease in the red blood cell (RBC) deformability (15) .
Plasma fibrinogen levels were determined using commercially available colorimetric kits (Sigma Chemical and Fibri-Prest, Diagnostica Stago, France).
Statistical Evaluation
Data analysis was performed using SPSS 10.0 Software. All the results are shown as medians with standard deviation (SD). Differences between the groups were analyzed using the unpaired non-parametric Mann-Whitney U-test. Differences were considered significant at p<0.05.
RESULTS
The mean values of Hct, RBC rigidity, plasma fibrinogen, PV and BV are shown in Table 1 . There were no significant differences between the control, POAD, and TAO groups when plasma fibrinogen values were compared. The Hct values of the TAO group were found to be significantly higher than the control and the PAOD groups (p<0.001 and p<0.001, respectively).
The comparison of PV among groups showed no significant difference. We investigated BV in two shear rates (BV1: 6.00 sec-1, BV2: 225 sec-1) to test the influence of vessel diameter on viscosity. BV1, which is representative of large sized arteries, was found to be significantly higher in the TAO group than the PAOD and the control groups (p<0.01 and p<0.05, respectively). BV2 represents the capillaries and was found to be significantly higher in PAOD and the TAO groups than the control group (p<0.001 and p<0.001, respectively). Similarly BV2 values of PAOD were significantly higher than those of the TAO group (p<0.05).
Tk, as an indicator of RBC rigidity was significantly higher in the PAOD and the TAO groups than the control group (p<0.05 and p<0.001, respectively) and Tk values of the PAOD group were found to be significantly higher than those of the TAO group (p<0.05).
DISCUSSION
TAO has a worldwide distribution; however, it is more prevalent in the Middle, Near, and Far East than in North America and Western Europe (1) . Although the number of patients with TAO in Japan and North America is declining due to the decrease in tobacco consumption (16) , it is still a major health problem in Turkey. According to data from the Turkish Ministry of Health, cigarette consumption has increased 36.2% between the years 1991 and 2000, which corresponds well with the increase in our TAO patients.
The ultimate aim for refractory TAO is the relief of rest pain and the prevention of amputation, so every effort should be made to save the BVI: blood viscosity at 6.0 1/s; BV2: blood viscosity at 225 1/s; PV: plasma viscosity; Tk: erythrocyte rigidity index. Values are mean±SD; p<0.05 implies statistical significance. limb in the active period of the disease. No forms of therapy are definitive except for discontinuation of tobacco use in TAO. There is a possible link between tobacco use and activation of the disease (17) . Surgical revascularization is rarely feasible due to occlusion of the small vessels distal to the popliteal artery and sympathectomy has a limited role in modern vascular practice (18) . There are studies concerning the use of iloprost, a prostaglandin analogue, showing its effectiveness in relieving rest pain and ulcer healing in TAO. In a prospective, randomized, double-blind study by Fishigen and Schafer, iloprost was superior to aspirin at 28 days with total relief of rest pain and complete healing of all trophic lesions with a response to therapy in 88% of patients receiving iloprost (19) .
There is a growing body of evidence concerning the possible link between impaired hemorheological parameters (blood viscosity, plasma viscosity, RBC rigidity) and the worsening of tissue ischemia in vascular atherosclerotic disease (4-7). However, altered macrocirculation and microcirculation have not been investigated extensively in patients with TAO. In this study, we investigated factors accepted as important determinants of flow conditions. The Hct value that influences blood viscosity in the macrocirculation was found to be significantly higher in the TAO group than the control and PAOD groups. There was no significant difference between the control and PAOD groups according to Hct values. Significantly increased Hct values in TAO might be attributed to acute tissue hypoxia in the lower limb due to the active period of the disease. Although increased Hct values are to be expected in PAOD group, compared to the control because of the chronic hypoxia, non-significant correlation of the Hct values between the control and PAOD groups may be attributed to highly increased RBC rigidity. Increased RBC rigidity results in a compensatory decrease in Hct as the rigid RBCs break down. In the Edinburg Artery Study, Hct and RBC values were found to be significantly related to the increasing severity of PAOD (5) . However, in other studies Hct values tended to be lower in the group of patients with severe chronic leg ischemia than in the group of patients without progression (20, 21) .
In this study, we encountered no significant difference between three groups in terms of fibrinogen values, which is the major determinant of plasma viscosity, and also in terms of plasma viscosity values. RBC rigidity is an important physiologic factor that plays an essential part in the delivery of oxygen to the tissues. RBC deformability allows individual RBCs, whose mean resting diameter averages 7 ,um, to pass through nutritive capillaries with diameters of no more than 3 to 5 Am. Oxygen-carrying capacity decreases as erythrocytes get stiffer and increased RBC rigidity results in impaired peripheral perfusion and tissue oxygenation (22, 23) . RBC rigidity (as Tk) was found to be significantly increased in TAO and PAOD groups, compared to the control group, and it was also significantly higher in PAOD group than the TAO group. The results of increased RBC rigidity in TAO and PAOD patients, compared to the controls are consistent with other reports (24, 25) .
Blood viscosity (BV) depends on shear rate, which means viscosity decreases as shear rate increases. The rheologic term "shear rate" is almost synonymous with velocity gradient. Shear rate is determined by the diameter of vessels. A high shear rate is being present when flow is fast and the vessel diameter is small; a low shear rate is present when flow is slow and the vessel diameter is large (26) . The non-Newtonian behavior of blood gives way to erythrocyte aggregation at low shear rates.
Furthermore, in capillaries high shear rates occur and BV will be low. For this reason, in the current study, BV was measured at two different shear rates. BV at a shear rate of 6.00 sec-1 (a low shear rate), which is representative of large sized arteries, was significantly higher in the TAO group than the PAOD and the control groups. This may be attributed to high Hct values in TAO because Hct is the major determinant of BV in macrocirculation. BV at a shear rate of 225 sec-1 (a high shear rate), which is representative of the capillary bed, was significantly higher in the TAO and PAOD groups than the control group.
Similarly it was significantly higher in the PAOD group than the TAO group. High Tk in TAO and PAOD groups may be the reason for high BV at a shear rate of 225 sec-1 because, as erythrocytes become less deformable, friction increases. Significantly higher BV values at a shear rate of 225 seconds in PAOD group than the control group are consistent with the other reported data (5, 27) .
Several papers have reported raised blood viscosity and RBC rigidity correlating with smoking intensity, which means reduced blood flow in smokers (28, 29) . In the clinical study by Haustein and colleagues, it was shown that smoking cessation improved the increased plasma fibrinogen, Hct, hemoglobin, and the white blood cell count. However, BV and RBC rigidity did not significantly change in the smoking abstainers group, which means smoking cessation may not immediately improve hemorheologic parameters in critical limb ischemia (30) . In TAO, although the only proven strategy to prevent progression of the disease and avoiding amputation is complete discontinuation of the cigarette smoking, amputation may still be inevitable in a group of patients who have stopped smoking (1) . TAO patients are young and active, so every effort should be exerted to improve distal arterial blood flow and tissue oxygenation to heal the ischemic lesions and to avoid major amputation. In the view of the current results, higher BV and RBC rigidity in TAO may be the contributing factors to tissue hypoxia and ischemic lesions. In the active period of the disease, drugs that address raised BV and RBC rigidity, such as pentoxifylline, may have beneficial effects on the healing of the ischemic lesions. Pentoxifylline has the potential to improve blood viscosity as well as RBC rigidity, and its role has been confirmed by some studies in the management of critical limb ischemia due to PAOD (8, 9) . We initiated a prospective clinical study addressing the effectiveness of intravenous pentoxifylline and iloprost in the acute phase of patients with TAO. The improvement of hemorheologic parameters in these patients with critical limb ischemia may be a new insight into the treatment of TAO.
CONCLUSION
Therapies that address impaired hemorheologic parameters may have beneficial effects on ulcer healing and prevent amputation in the active period of TAO. Further studies are already underway to elucidate the role of drugs that improve increased blood viscosity and RBC rigidity in patients with TAO.
